Evidence map›Paper›PMID 30065147›Full record

ArticleMolecules (Basel, Switzerland)2018

Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model.

Behzad Sharif Makhmal Zadeh, Golbarg Esfahani, Anayatollah Salimi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Behzad Sharif Makhmal ZadehNanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Golestan Ave, Ahvaz 67123, Iran. makhmalzadeh@yahoo.com.ORCID 0000-0002-1441-3127
Golbarg EsfahaniNanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Golestan Ave, Ahvaz 67123, Iran. golbarg_isfahani@yahoo.com.
Anayatollah SalimiNanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Golestan Ave, Ahvaz 67123, Iran. anayatsalimi2003@yahoo.com.
Ahvaz Jundishapur University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The low oral bioavailability of ciprofloxacin is associated with two distinct challenges: its low aqueous solubility and efflux by p-glycoproteins (P-gp) in the intestinal membrane. Several studies were conducted in order to improve its solubility and permeability through the gastrointestinal membrane. In this study, in a full factorial design study, eight polymeric micelles were prepared and their characteristics, including particle size, loading and release rate were evaluated. Polymeric micelles demonstrated particle sizes below 190 nm and 27⁻88% loading efficiency. Drug release was affected by drug solubility, polymeric micelle erosion and swelling in simulated gastrointestinal fluids. An optimized polymeric micelle was prepared based on appropriate characteristics such as high drug loading and low particle size; and was used for a permeation study on Caco-2 cells. Optimized polymeric micelles with and without ginsenoside and ginsenoside alone enhanced drug permeability through Caco-2 cells significantly in the absorptive direction. The effect of ginsenoside was dose dependent and the maximum effect was seen in 0.23 mg/mL concentration. Results showed that P-gp may not be responsible for ciprofloxacin secretion into the gut. The main mechanism of ciprofloxacin transport through Caco-2 cells in both directions is active diffusion and P-gp has inhibitory effects on ciprofloxacin permeability in the absorptive direction that was blocked by ginsenoside and micelles without ginsenoside.

Indexed as

Drug CarriersAnti-Bacterial AgentsATP Binding Cassette Transporter, Subfamily BBiological AvailabilityBiological TransportCaco-2 CellsCell Membrane PermeabilityCiprofloxacinDiffusionDrug CompoundingDrug LiberationGene ExpressionGinsenosidesHumansIntestinal AbsorptionKineticsAnti-Bacterial AgentsATP Binding Cassette Transporter, Subfamily BCiprofloxacinDrug CarriersGinsenosidesMicellesciprofloxacingastrointestinal drug transporterginsenosideP-glycoproteinpolymeric micelles

Identifiers

PMID30065147
PMCPMC6222528
OpenAlexW2887698868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.